FI935728A0 - Substituent 4-phenylpyridone and 4-phenyl-2-alkoxypyridine - Google Patents
Substituent 4-phenylpyridone and 4-phenyl-2-alkoxypyridineInfo
- Publication number
- FI935728A0 FI935728A0 FI935728A FI935728A FI935728A0 FI 935728 A0 FI935728 A0 FI 935728A0 FI 935728 A FI935728 A FI 935728A FI 935728 A FI935728 A FI 935728A FI 935728 A0 FI935728 A0 FI 935728A0
- Authority
- FI
- Finland
- Prior art keywords
- phenyl
- alkoxypyridine
- phenylpyridone
- substituent
- phenylpyridones
- Prior art date
Links
- DNUDULSSNHKPHP-UHFFFAOYSA-N 4-phenyl-1h-pyridin-2-one Chemical compound C1=NC(O)=CC(C=2C=CC=CC=2)=C1 DNUDULSSNHKPHP-UHFFFAOYSA-N 0.000 title abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 2
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Substituted 4-phenylpyridones and 4-phenyl-2-alkoxypyridines are prepared by reducing corresponding 4-phenylpyridone derivatives and 4-phenyl-2-alkoxypyridine derivatives, respectively. The substituted 4-phenylpyridones and 4-phenyl-2-alkoxypyridines may be employed as active compounds in drugs (medicaments, pharmaceuticals, medicines), in particular for the treatment of hyperlipoproteinaemia.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4243278 | 1992-12-21 | ||
DE4321421A DE4321421A1 (en) | 1992-12-21 | 1993-06-28 | Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines |
Publications (2)
Publication Number | Publication Date |
---|---|
FI935728A0 true FI935728A0 (en) | 1993-12-20 |
FI935728A FI935728A (en) | 1994-06-22 |
Family
ID=25921579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI935728A FI935728A (en) | 1992-12-21 | 1993-12-20 | Substituted 4-phenylpyridones and 4-phenyl-2-alkoxypyridines |
Country Status (21)
Country | Link |
---|---|
US (1) | US5418243A (en) |
EP (1) | EP0603649B1 (en) |
JP (1) | JPH06234741A (en) |
CN (1) | CN1117965A (en) |
AT (1) | ATE140226T1 (en) |
AU (1) | AU660132B2 (en) |
CA (1) | CA2111778A1 (en) |
CZ (1) | CZ284093A3 (en) |
DE (1) | DE59303195D1 (en) |
DK (1) | DK0603649T3 (en) |
ES (1) | ES2089687T3 (en) |
FI (1) | FI935728A (en) |
GR (1) | GR3020668T3 (en) |
HU (1) | HUT70150A (en) |
IL (1) | IL108071A0 (en) |
MX (1) | MX9308013A (en) |
NO (1) | NO934706L (en) |
NZ (1) | NZ250500A (en) |
PH (1) | PH29953A (en) |
PL (1) | PL301582A1 (en) |
SK (1) | SK144893A3 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19627420A1 (en) * | 1996-07-08 | 1998-01-15 | Bayer Ag | 6- (hydroxymethyl-ethyl) pyridine |
JP2005126340A (en) * | 2003-10-22 | 2005-05-19 | Kureha Chem Ind Co Ltd | Method for producing substituted pyridone compounds, raw material compound thereof and method for producing the same |
AR059898A1 (en) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | DERIVATIVES OF 3-CIANO-PIRIDONA 1,4-DISUSTITUTED AND ITS USE AS ALLOSTERIC MODULATORS OF MGLUR2 RECEIVERS |
TW200845978A (en) * | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
NZ584145A (en) | 2007-09-14 | 2012-03-30 | Ortho Mcneil Janssen Pharm | 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1,4'] bipyridinyl-2'-ones |
EA019085B1 (en) * | 2007-09-14 | 2014-01-30 | Янссен Фармасьютикалз, Инк. | 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
EP2205565B1 (en) * | 2007-09-14 | 2013-04-17 | Janssen Pharmaceuticals, Inc. | 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones |
MX2010005110A (en) * | 2007-11-14 | 2010-09-09 | Ortho Mcneil Janssen Pharm | Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors. |
ES2439291T3 (en) | 2008-09-02 | 2014-01-22 | Janssen Pharmaceuticals, Inc. | 3-Azabicyclo [3.1.0] hexyl derivatives as modulators of metabotropic glutamate receptors |
US8697689B2 (en) | 2008-10-16 | 2014-04-15 | Janssen Pharmaceuticals, Inc. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
MX2011005242A (en) | 2008-11-28 | 2011-09-06 | Ortho Mcneil Janssen Pharm | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors. |
MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
MY161325A (en) | 2009-05-12 | 2017-04-14 | Janssen Pharmaceuticals Inc | 1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
CA2760259C (en) | 2009-05-12 | 2018-05-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
ES2536433T3 (en) | 2010-11-08 | 2015-05-25 | Janssen Pharmaceuticals, Inc. | 1,2,4-Triazolo [4,3-a] pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
JP5852664B2 (en) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | 1,2,4-Triazolo [4,3-a] pyridine derivatives and their use as positive allosteric modulators of the mGluR2 receptor |
CN103298809B (en) | 2010-11-08 | 2016-08-31 | 杨森制药公司 | 1,2,4-triazol [4,3-a] pyridine derivate and the purposes of the positive allosteric modulators as MGLUR2 acceptor thereof |
JO3368B1 (en) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
JO3367B1 (en) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
ME03518B (en) | 2014-01-21 | 2020-04-20 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
WO2015110435A1 (en) | 2014-01-21 | 2015-07-30 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
CN104370806B (en) * | 2014-06-17 | 2017-07-07 | 中国海洋大学 | A kind of pyridone alkaloid compound and its production and use |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4154838A (en) * | 1975-07-31 | 1979-05-15 | Smith Kline & French Laboratories Limited | Alkoxy pyridine |
GB1564502A (en) * | 1975-07-31 | 1980-04-10 | Smith Kline French Lab | Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives |
US4684477A (en) * | 1985-03-06 | 1987-08-04 | Chisso Corporation | Pyridine derivatives and their use in liquid crystals |
US4906624A (en) * | 1987-09-08 | 1990-03-06 | Warner-Lambert Company | 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
EP0339342A1 (en) * | 1988-04-23 | 1989-11-02 | Bayer Ag | N-substituted N-amino pyrroles |
US4916239A (en) * | 1988-07-19 | 1990-04-10 | Merck & Co., Inc. | Process for the lactonization of mevinic acids and analogs thereof |
US5032602A (en) * | 1988-12-14 | 1991-07-16 | Bayer Aktiengesellschaft | Inhibiting HMG-CoA reductase with novel substituted 2-pyridones and pyrid-2-thiones |
DE3909378A1 (en) * | 1989-03-22 | 1990-09-27 | Bayer Ag | SUBSTITUTED BIPHENYLE |
DE3925636A1 (en) * | 1989-08-03 | 1991-02-07 | Bayer Ag | IMINO-SUBSTITUTED PYRIDINE |
-
1993
- 1993-11-25 AU AU51955/93A patent/AU660132B2/en not_active Ceased
- 1993-12-08 AT AT93119766T patent/ATE140226T1/en not_active IP Right Cessation
- 1993-12-08 DE DE59303195T patent/DE59303195D1/en not_active Expired - Fee Related
- 1993-12-08 ES ES93119766T patent/ES2089687T3/en not_active Expired - Lifetime
- 1993-12-08 DK DK93119766.9T patent/DK0603649T3/en active
- 1993-12-08 EP EP93119766A patent/EP0603649B1/en not_active Expired - Lifetime
- 1993-12-14 US US08/166,775 patent/US5418243A/en not_active Expired - Fee Related
- 1993-12-15 MX MX9308013A patent/MX9308013A/en not_active Application Discontinuation
- 1993-12-17 CA CA002111778A patent/CA2111778A1/en not_active Abandoned
- 1993-12-17 NZ NZ250500A patent/NZ250500A/en unknown
- 1993-12-17 IL IL10807193A patent/IL108071A0/en unknown
- 1993-12-20 FI FI935728A patent/FI935728A/en unknown
- 1993-12-20 PH PH47501A patent/PH29953A/en unknown
- 1993-12-20 CZ CZ932840A patent/CZ284093A3/en unknown
- 1993-12-20 PL PL93301582A patent/PL301582A1/en unknown
- 1993-12-20 NO NO934706A patent/NO934706L/en unknown
- 1993-12-20 JP JP5344533A patent/JPH06234741A/en active Pending
- 1993-12-20 SK SK1448-93A patent/SK144893A3/en unknown
- 1993-12-20 HU HU9303675A patent/HUT70150A/en unknown
- 1993-12-21 CN CN93112965A patent/CN1117965A/en active Pending
-
1996
- 1996-07-31 GR GR960402026T patent/GR3020668T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0603649B1 (en) | 1996-07-10 |
PH29953A (en) | 1996-09-16 |
DK0603649T3 (en) | 1996-11-04 |
EP0603649A1 (en) | 1994-06-29 |
CA2111778A1 (en) | 1994-06-22 |
NO934706D0 (en) | 1993-12-20 |
US5418243A (en) | 1995-05-23 |
ES2089687T3 (en) | 1996-10-01 |
CN1117965A (en) | 1996-03-06 |
NZ250500A (en) | 1996-02-27 |
AU5195593A (en) | 1994-06-30 |
HU9303675D0 (en) | 1994-04-28 |
PL301582A1 (en) | 1994-06-27 |
ATE140226T1 (en) | 1996-07-15 |
DE59303195D1 (en) | 1996-08-14 |
MX9308013A (en) | 1994-08-31 |
HUT70150A (en) | 1995-09-28 |
FI935728A (en) | 1994-06-22 |
IL108071A0 (en) | 1994-04-12 |
NO934706L (en) | 1994-06-22 |
GR3020668T3 (en) | 1996-10-31 |
JPH06234741A (en) | 1994-08-23 |
AU660132B2 (en) | 1995-06-08 |
CZ284093A3 (en) | 1994-07-13 |
SK144893A3 (en) | 1995-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI935728A0 (en) | Substituent 4-phenylpyridone and 4-phenyl-2-alkoxypyridine | |
DE59310399D1 (en) | Prodrugs, their preparation and use as medicines | |
FI942074A0 (en) | nor- bile acid derivatives, process for their preparation and use of these compounds as drugs | |
DE69011059D1 (en) | Heterocyclic acylaminothiazole derivatives, their preparation and pharmaceutical preparations containing them. | |
NO891415D0 (en) | PREPARATION OF SUBSTITUTED FLAVONOID COMPOUNDS AND SALTS AND PHARMACEUTICAL PREPARATIONS THEREOF. | |
ATE110071T1 (en) | PYRIDAZINONE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
ATE173627T1 (en) | MEDICAL COMPOSITION | |
FI924285A (en) | 4-DESOXY-4-EPIPODOPHYLLOTOXINDERIVAT ELLER ETT PHARMACEUTICAL COMPEPTABELT SALT DAERAV | |
DK77588A (en) | PROSTAGLANDIN E1 DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
NO306468B1 (en) | New phospholipid derivatives, their preparation, drug containing the derivatives and the use of the derivatives | |
ATE147741T1 (en) | SUBSTITUTED PYRIDINES AS HMG-COA REDUCTASE INHITORS | |
IL106107A (en) | Imidazolyl-substituted cyclohexane derivatives, their preparation and pharmaceutical compositions containing them | |
DE69012742D1 (en) | Azole derivatives and fungicidal drugs containing them as active components. |